The British Pharmaceutical AstraZeneca, together with the University of Oxford, submitted all data on their vaccine to the British medicine watchdog MHRA for approval. Earlier this month, the vaccines from the American companies Pfizer and Moderna came on the market.
The British pharmaceutical company AstraZeneca, which has developed a vaccine together with the University of Oxford, says that the vaccine can also prevent people from becoming ill from the mutated virus recently found in the United Kingdom.
This would be shown by studies carried out by the company. According to AstraZeneca, the changes in the genetic code of this new viral strain are not able to alter the structure of the protein and thus the vaccine also works with the mutated virus.
In October the Netherlands and other European countries ordered 300 million doses from AstraZeneca. They will actually be taken once the vaccine has been proven. The European Commission has made similar deals with five other manufacturers.